Alumis (ALMS) Cash & Equivalents (2023 - 2025)
Alumis' (ALMS) quarterly Cash & Equivalents came in at $89.7 million in Q4 2025, down 47.11% year-on-year from $169.5 million in Q4 2024, and up 37.41% on a QoQ basis from $65.3 million in Q3 2025.
Alumis (ALMS) Cash & Equivalents (2023 - 2025) Analysis & Trends
Alumis (ALMS) has 3 years of Cash & Equivalents data on file, last reported at $89.7 million in Q4 2025.
- On a quarterly basis, Cash & Equivalents fell 47.11% year-over-year to $89.7 million in Q4 2025; TTM through Dec 2025 was $89.7 million, a 47.11% decrease from a year earlier, with the FY2025 full-year figure at $89.7 million, down 47.11% from the prior year.
- Cash & Equivalents for Q4 2025 stood at $89.7 million, up from $65.3 million in the prior quarter.
- Over the last five years, Cash & Equivalents for ALMS reached as high as $213.4 million in Q3 2024 and fell as low as $46.0 million in Q4 2023.
- Historically, Cash & Equivalents has averaged $115.0 million across 3 years, with a median of $112.1 million in 2024.
- Across the five-year window, Cash & Equivalents jumped 295.68% in 2024 and sank 69.42% in 2025, its largest moves.
- Year by year, Cash & Equivalents stood at $46.0 million in 2023, then surged by 268.57% to $169.5 million in 2024, then sank by 47.11% to $89.7 million in 2025.
- Per Business Quant data, the three most recent Cash & Equivalents figures were $89.7 million in Q4 2025, $65.3 million in Q3 2025, and $151.8 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 82.45 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 5.49 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 3.58 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 440.94 Mn |
| 10 | Alumis | 2.41 Bn | 2.10 Bn | - | 89.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 89.67 Mn |
| Sep 30, 2025 | 65.26 Mn |
| Jun 30, 2025 | 151.75 Mn |
| Mar 31, 2025 | 128.54 Mn |
| Dec 31, 2024 | 169.53 Mn |
| Sep 30, 2024 | 213.42 Mn |
| Jun 30, 2024 | 155.11 Mn |
| Mar 31, 2024 | 112.07 Mn |
| Dec 31, 2023 | 46.00 Mn |
| Sep 30, 2023 | 53.94 Mn |
| Jun 30, 2023 | 79.56 Mn |